MANAGING CYTOKINE RELEASE SYNDROME (CRS) AND NEUROTOXICITY WITH STEP-UP DOSING OF MOSUNETUZUMAB IN RELAPSED/REFRACTORY (R/R) B-CELL NON-HODGKIN LYMPHOMA (NHL)

作     者：L.H. Sehn S. Assouline N.L. Bartlett F. Bosch C.M. Diefenbach I. Flinn J.Y. Hong W.S. Kim M. Matasar L. Nastoupil S.J. Schuster M. Shadman S.S. Yoon B. Bender W. Chu G.M. Hernandez A. Kwan B. McCall I. Sison C. Wang M.C. Wei S. Yin K. Yousefi L.E. Budde 

作者机构：Medical Oncology BC Cancer Centre for Lymphoid Cancer and University of British Columbia Vancouver BC Canada Division of Hematology Jewish General Hospital Montréal QC Canada Siteman Cancer Center Washington University School of Medicine St. Louis MO United States Department of Hematology University Hospital Vall d'Hebron Barcelona Spain Department of Hematology/Oncology New York University Medical Center Brooklyn NY United States Blood Cancer Research Program Sarah Cannon Research Institute/Tennessee Oncology Nashville TN United States Department of Oncology ASAN Medical Center Seoul Republic of Korea Division of Hematology-Oncology Department of Internal Medicine Samsung Medical Center Seoul Republic of Korea Lymphoma Service Division of Hematologic Oncology Department of Medicine Memorial Sloan Kettering Cancer Center New York NY United States Department of Lymphoma and Myeloma Division of Cancer Medicine The University of Texas MD Anderson Cancer Center Houston TX United States Department of Medicine Division of Hematology-Oncology University of Pennsylvania Philadelphia PA United States Medical Oncology Division Department of Medicine Fred Hutchinson Cancer Research Center Seattle WA United States Division of Hematology/Medical Oncology Department of Internal Medicine Seoul National University Hospital Seoul Republic of Korea Clinical Pharmacology Development Genentech Inc. South San Francisco CA United States Product Development Oncology Genentech Inc. South San Francisco CA United States Oncology Biomarker Development Genentech Inc. South San Francisco CA United States Safety Science Oncology Genentech Inc. South San Francisco CA United States Clinical Operations gRED Genentech Inc. South San Francisco CA United States Product Development Biometrics Biostatistics Genentech Inc. South San Francisco CA United States Department of Hematology and Hematopoietic Cell Transplantation City of Hope Comprehensive Cancer Center Duarte CA United States 

出 版 物：《Hematological Oncology》 

年 卷 期：2019年第37卷第S2期

学科分类：1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学]